103 related articles for article (PubMed ID: 32054954)
41. c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma.
Oyarzo MP; Medeiros LJ; Atwell C; Feretzaki M; Leventaki V; Drakos E; Amin HM; Rassidakis GZ
Blood; 2006 Mar; 107(6):2544-7. PubMed ID: 16304056
[TBL] [Abstract][Full Text] [Related]
42. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
[TBL] [Abstract][Full Text] [Related]
43. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
44. [Expression of ALK protein in large cell lymphoma with ALCL chromosome translocation in relation to prognosis].
Ji TH; Li HL; Jiang HY; Zhao T; Yu YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):543-6. PubMed ID: 18549625
[TBL] [Abstract][Full Text] [Related]
45. Synergistic Effect of Alectinib and Everolimus on ALK-positive Anaplastic Large Cell Lymphoma Growth Inhibition.
Kim D; Koh Y; Yoon SS
Anticancer Res; 2020 Mar; 40(3):1395-1403. PubMed ID: 32132036
[TBL] [Abstract][Full Text] [Related]
46. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
47. Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.
Zou CY; Guan GF; Zhu C; Liu TQ; Guo Q; Cheng W; Wu AH
CNS Neurosci Ther; 2019 Mar; 25(3):333-342. PubMed ID: 30105842
[TBL] [Abstract][Full Text] [Related]
48. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
49. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
Oyarzo MP; Drakos E; Atwell C; Amin HM; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
[TBL] [Abstract][Full Text] [Related]
50. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
[No Abstract] [Full Text] [Related]
51. Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
Bobos M; Kotoula V; Kaloutsi V; Karayannopoulou G; Papadimitriou CS; Kostopoulos I
Histol Histopathol; 2009 Aug; 24(8):1035-48. PubMed ID: 19554511
[TBL] [Abstract][Full Text] [Related]
52. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
[TBL] [Abstract][Full Text] [Related]
53. The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.
Kitamura N; Katagiri YU; Itagaki M; Miyagawa Y; Onda K; Okita H; Mori A; Fujimoto J; Kiyokawa N
Leuk Res; 2009 Jul; 33(7):908-12. PubMed ID: 19243819
[TBL] [Abstract][Full Text] [Related]
54. The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.
Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R
Cancer Res; 2008 Nov; 68(21):8899-907. PubMed ID: 18974134
[TBL] [Abstract][Full Text] [Related]
55. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
56. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma.
Wang X; Wu J; Zhang M
Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226
[TBL] [Abstract][Full Text] [Related]
57. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
[TBL] [Abstract][Full Text] [Related]
58. Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features.
Hodges KB; Collins RD; Greer JP; Kadin ME; Kinney MC
Am J Surg Pathol; 1999 Jan; 23(1):49-58. PubMed ID: 9888703
[TBL] [Abstract][Full Text] [Related]
59. CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation.
Miyagaki T; Sugaya M; Murakami T; Asano Y; Tada Y; Kadono T; Okochi H; Tamaki K; Sato S
Cancer Res; 2011 Mar; 71(6):2056-65. PubMed ID: 21406396
[TBL] [Abstract][Full Text] [Related]
60. Most of CD30+ anaplastic large cell lymphoma of B cell type show a somatic mutation in the IgH V region genes.
Kuze T; Nakamura N; Hashimoto Y; Abe M
Leukemia; 1998 May; 12(5):753-7. PubMed ID: 9593274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
